Report Detail

Other Global Cox-2 Inhibitors Market Size, Status and Forecast 2019-2025

  • RnM3251561
  • |
  • 03 April, 2019
  • |
  • Global
  • |
  • 92 Pages
  • |
  • QYResearch
  • |
  • Other

Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.
In 2018, the global Cox-2 Inhibitors market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cox-2 Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cox-2 Inhibitors development in United States, Europe and China.

The key players covered in this study
Bayer
Novartis
Pfizer
Merck
Cadila Pharmaceuticals
Sabinsa Corporation
...

Market segment by Type, the product can be split into
Selective Cox-2 Inhibitors
Non Selective Cox-2 Inhibitors

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cox-2 Inhibitors status, future forecast, growth opportunity, key market and key players.
To present the Cox-2 Inhibitors development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cox-2 Inhibitors are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Cox-2 Inhibitors Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Selective Cox-2 Inhibitors
      • 1.4.3 Non Selective Cox-2 Inhibitors
    • 1.5 Market by Application
      • 1.5.1 Global Cox-2 Inhibitors Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Retail Pharmacies
      • 1.5.4 Online Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Cox-2 Inhibitors Market Size
    • 2.2 Cox-2 Inhibitors Growth Trends by Regions
      • 2.2.1 Cox-2 Inhibitors Market Size by Regions (2014-2025)
      • 2.2.2 Cox-2 Inhibitors Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Cox-2 Inhibitors Market Size by Manufacturers
      • 3.1.1 Global Cox-2 Inhibitors Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Cox-2 Inhibitors Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Cox-2 Inhibitors Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cox-2 Inhibitors Key Players Head office and Area Served
    • 3.3 Key Players Cox-2 Inhibitors Product/Solution/Service
    • 3.4 Date of Enter into Cox-2 Inhibitors Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Cox-2 Inhibitors Market Size by Type (2014-2019)
    • 4.2 Global Cox-2 Inhibitors Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Cox-2 Inhibitors Market Size (2014-2019)
    • 5.2 Cox-2 Inhibitors Key Players in United States
    • 5.3 United States Cox-2 Inhibitors Market Size by Type
    • 5.4 United States Cox-2 Inhibitors Market Size by Application

    6 Europe

    • 6.1 Europe Cox-2 Inhibitors Market Size (2014-2019)
    • 6.2 Cox-2 Inhibitors Key Players in Europe
    • 6.3 Europe Cox-2 Inhibitors Market Size by Type
    • 6.4 Europe Cox-2 Inhibitors Market Size by Application

    7 China

    • 7.1 China Cox-2 Inhibitors Market Size (2014-2019)
    • 7.2 Cox-2 Inhibitors Key Players in China
    • 7.3 China Cox-2 Inhibitors Market Size by Type
    • 7.4 China Cox-2 Inhibitors Market Size by Application

    8 Japan

    • 8.1 Japan Cox-2 Inhibitors Market Size (2014-2019)
    • 8.2 Cox-2 Inhibitors Key Players in Japan
    • 8.3 Japan Cox-2 Inhibitors Market Size by Type
    • 8.4 Japan Cox-2 Inhibitors Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Cox-2 Inhibitors Market Size (2014-2019)
    • 9.2 Cox-2 Inhibitors Key Players in Southeast Asia
    • 9.3 Southeast Asia Cox-2 Inhibitors Market Size by Type
    • 9.4 Southeast Asia Cox-2 Inhibitors Market Size by Application

    10 India

    • 10.1 India Cox-2 Inhibitors Market Size (2014-2019)
    • 10.2 Cox-2 Inhibitors Key Players in India
    • 10.3 India Cox-2 Inhibitors Market Size by Type
    • 10.4 India Cox-2 Inhibitors Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Cox-2 Inhibitors Market Size (2014-2019)
    • 11.2 Cox-2 Inhibitors Key Players in Central & South America
    • 11.3 Central & South America Cox-2 Inhibitors Market Size by Type
    • 11.4 Central & South America Cox-2 Inhibitors Market Size by Application

    12 International Players Profiles

    • 12.1 Bayer
      • 12.1.1 Bayer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Cox-2 Inhibitors Introduction
      • 12.1.4 Bayer Revenue in Cox-2 Inhibitors Business (2014-2019)
      • 12.1.5 Bayer Recent Development
    • 12.2 Novartis
      • 12.2.1 Novartis Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Cox-2 Inhibitors Introduction
      • 12.2.4 Novartis Revenue in Cox-2 Inhibitors Business (2014-2019)
      • 12.2.5 Novartis Recent Development
    • 12.3 Pfizer
      • 12.3.1 Pfizer Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Cox-2 Inhibitors Introduction
      • 12.3.4 Pfizer Revenue in Cox-2 Inhibitors Business (2014-2019)
      • 12.3.5 Pfizer Recent Development
    • 12.4 Merck
      • 12.4.1 Merck Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Cox-2 Inhibitors Introduction
      • 12.4.4 Merck Revenue in Cox-2 Inhibitors Business (2014-2019)
      • 12.4.5 Merck Recent Development
    • 12.5 Cadila Pharmaceuticals
      • 12.5.1 Cadila Pharmaceuticals Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Cox-2 Inhibitors Introduction
      • 12.5.4 Cadila Pharmaceuticals Revenue in Cox-2 Inhibitors Business (2014-2019)
      • 12.5.5 Cadila Pharmaceuticals Recent Development
    • 12.6 Sabinsa Corporation
      • 12.6.1 Sabinsa Corporation Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Cox-2 Inhibitors Introduction
      • 12.6.4 Sabinsa Corporation Revenue in Cox-2 Inhibitors Business (2014-2019)
      • 12.6.5 Sabinsa Corporation Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Cox-2 Inhibitors . Industry analysis & Market Report on Cox-2 Inhibitors is a syndicated market report, published as Global Cox-2 Inhibitors Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Cox-2 Inhibitors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,088.80
      4,633.20
      6,177.60
      3,603.60
      5,405.40
      7,207.20
      590,031.00
      885,046.50
      1,180,062.00
      325,143.00
      487,714.50
      650,286.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report